D. M. Johnson

发表

Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

D. Marsden, T. Zytkovicz, E. Fitzgerald, 2001, Clinical chemistry.

In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.

Jerome J. Schentag, R. Jones, D. M. Johnson, 1998, Diagnostic microbiology and infectious disease.

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.

Jerome J. Schentag, R. Jones, D. M. Johnson, 1997, Diagnostic microbiology and infectious disease.

Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.

J. Hindler, G. Doern, R. Jones, 1996, Diagnostic microbiology and infectious disease.

Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.

R. Jones, D. M. Johnson, M. S. Barrett, 1991, Journal of chemotherapy.

In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.

R. Jones, D. M. Johnson, C. M. Flynn, 1996, Journal of chemotherapy.

Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.

R. Jones, D. M. Johnson, 1996, Diagnostic microbiology and infectious disease.

Membrane permeability as a determinant of dexamethasone resistance in murine thymoma cells.

S. Bourgeois, D. M. Johnson, R. Newby, 1984, Cancer research.

Estrogen stimulates growth hormone and somatomedin-C in castrate and intact female baboons.

K. Copeland, D. M. Johnson, T. Kuehl, 1984, The Journal of clinical endocrinology and metabolism.

Antimicrobial activity of ten macrolide, linsosamine and streptogramin drugs tested againstLegionella species

R. Jones, D. M. Johnson, M. S. Barrett, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates

R. Jones, D. M. Johnson, M. S. Barrett, 1992, Antimicrobial Agents and Chemotherapy.

In Vitro Evaluation of BI 397, a Novel Glycopeptide Antimicrobial Agent

M. Pfaller, R. Jones, D. M. Johnson, 2001, Journal of chemotherapy.

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

R. Jones, D. M. Johnson, M. S. Barrett, 1991, Diagnostic microbiology and infectious disease.

Physical model for gas―solid chromatography with volatile and nonvolatile modifiers

D. M. Johnson, J. F. Parcher, P. Lin, 1986 .

Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines.

R. Jones, D. M. Johnson, M. Erwin, 1999, Diagnostic microbiology and infectious disease.

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

R. Jones, D. M. Johnson, M. Erwin, 1996, Antimicrobial agents and chemotherapy.

Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates.

R. Jones, D. M. Johnson, S. Marshall, 1995, Diagnostic microbiology and infectious disease.

Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates.

R. Jones, D. M. Johnson, 1995, Diagnostic microbiology and infectious disease.

In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin

R. Jones, D. M. Johnson, M. S. Barrett, 1991, Antimicrobial Agents and Chemotherapy.

Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.

R. Jones, D. M. Johnson, M. S. Barrett, 1991, Diagnostic microbiology and infectious disease.

In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester.

R. Jones, D. M. Johnson, M. S. Barrett, 1991, Diagnostic microbiology and infectious disease.

Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.

Ronald N. Jones, T. Fritsche, D. M. Johnson, 2003, Diagnostic microbiology and infectious disease.

Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group.

M. Pfaller, R. Jones, D. M. Johnson, 1999, Diagnostic microbiology and infectious disease.

Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone.

M. Pfaller, R. Jones, D. M. Johnson, 1999, Diagnostic microbiology and infectious disease.

In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.

R. Jones, D. M. Johnson, M. Erwin, 1991, Diagnostic microbiology and infectious disease.

Preparation of human factor D of the alternative pathway of complement.

K. Reid, J. Gagnon, D. M. Johnson, 1981, Methods in enzymology.

Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection.

D. M. Johnson, J. Flood, S. A. Volpicelli, 1991, Clinical chemistry.

Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.

M. Pfaller, R. Jones, D. M. Johnson, 2000, Diagnostic microbiology and infectious disease.

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.

R. Jones, D. M. Johnson, D. Biedenbach, 2000, Diagnostic microbiology and infectious disease.

In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones.

R. Jones, D. M. Johnson, M. Erwin, 1993, Diagnostic microbiology and infectious disease.

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.

R. Jones, D. M. Johnson, D. Biedenbach, 1999, Diagnostic microbiology and infectious disease.

Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.

R. Jones, D. M. Johnson, M. Erwin, 1991, Diagnostic microbiology and infectious disease.

Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.

J. Gagnon, D. M. Johnson, K. Reid, 1980, The Biochemical journal.

In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group.

R. Jones, D. M. Johnson, D. Biedenbach, 1999, Diagnostic microbiology and infectious disease.

Radioimmunoassay of somatomedin‐C in the baboon (Papio cynocephalus): A comparison of multiple techniques of measurement

K. Copeland, J. V. Van Wyk, D. M. Johnson, 1983, American journal of primatology.

Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218

R. Jones, D. M. Johnson, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.

M. Cormican, R. Jones, D. M. Johnson, 1996, Diagnostic microbiology and infectious disease.

Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.

R. Jones, D. M. Johnson, 1998, Diagnostic microbiology and infectious disease.

Antimicrobial Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia spp.

R. Jones, D. M. Johnson, S. Marshall, 1999, Drugs.

In Vitro Antimicrobial Activity of Gatifloxacin Against N. gonorrhoeae and H. influenzae

M. Pfaller, G. Doern, R. Jones, 1999, Drugs.

Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

M. Pfaller, R. Jones, D. M. Johnson, 1998, Journal of Antimicrobial Chemotherapy.

Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.

D. M. Johnson, P. Kiely, P. Kiely, 2002, Rheumatology.

Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial

David M. Liebovitz, Tejas Mehta, D. Boulware, 2023, medRxiv.